XML 59 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of stock options and stock appreciation rights activity The following table summarizes stock appreciation rights activity:
Stock Appreciation RightsSharesWeighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
 in thousandsin thousands
Outstanding at December 28, 2019509 $76.13 2.5$— 
Granted— — 
Exercised— — — 
Forfeited or expired(126)79.44 
Outstanding at January 2, 2021383 75.05 1.9— 
Granted— — 
Exercised— — — 
Forfeited or expired(101)82.57 
Outstanding at January 1, 2022282 72.34 1.5— 
Granted— — 
Exercised— — — 
Forfeited or expired(181)81.57 
Outstanding at December 31, 2022101 55.31 0.9— 
Exercisable at December 31, 2022101 $55.31 0.9$— 
Summary of stock options and stock appreciation rights outstanding and exercisable The following table summarizes information with respect to stock appreciation rights outstanding and exercisable at December 31, 2022:
Stock Appreciation Rights OutstandingStock Appreciation
Rights Exercisable
Range of Exercise PricesNumber of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual
Term (Years)
Number of
Shares
Weighted-
Average
Exercise
Price
in thousandsin thousands
$36.73 - $80.22
101 55.31 0.9101 55.31 
Total101 $55.31 0.9101 $55.31 
Summary of restricted stock and restricted stock unit activity The following table summarizes restricted stock, restricted stock unit and performance restricted stock unit activity:
Restricted Stock Units and Performance Restricted Stock UnitsNumber of
Shares
Weighted-Average
Grant Date Fair
Value Per Share
 in thousands
Nonvested at December 28, 20192,329 $15.16 
Granted1,124 3.76 
Vested(1,127)16.42 
Forfeited(590)12.42 
Nonvested at January 2, 20211,736 $7.90 
Granted1,033 13.19 
Vested(861)9.80 
Forfeited(68)9.42 
Nonvested at January 1, 20221,840 $9.93 
Granted1,292 10.52 
Vested(936)10.16 
Forfeited(229)10.79 
Nonvested at December 31, 20221,967 $10.08